Evotec SE Stock Other OTC
Equities
EVTCY
US30050E1055
Biotechnology & Medical Research
Sales 2024 * | 882M 954M | Sales 2025 * | 1.03B 1.12B | Capitalization | 1.63B 1.76B |
---|---|---|---|---|---|
Net income 2024 * | -34M -36.76M | Net income 2025 * | 31M 33.51M | EV / Sales 2024 * | 2.16 x |
Net Debt 2024 * | 278M 301M | Net Debt 2025 * | 235M 254M | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
-39.5
x | P/E ratio 2025 * |
35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |